Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Novo Nordisk Just Made a Big Move in the Weight Loss Drug Market. Should You Worry About Rival Eli Lilly?
03:40am, Thursday, 20'th Nov 2025
Novo Nordisk and Eli Lilly make the world's top-selling weight loss drugs. These products have driven the companies' revenue growth in recent years.
Researchers move closer to matching patients with GLP-1 drug that works best for them
05:59pm, Wednesday, 19'th Nov 2025
U.S. researchers are beginning to identify clinical characteristics that distinguish “super responders” to GLP-1 weight-loss drugs like Wegovy and Zepbound from patients who lose only moderate amo
Down 45% Year-to-Date, Novo Nordisk Ignites a Price War
01:04pm, Wednesday, 19'th Nov 2025
For investors in Novo Nordisk NYSE: NVO, 2025 has been a challenging year. After reaching a 52-week high of over $112, the stock has declined by approximately 45%, reflecting mounting competitive pre
Should Investors Buy Novo Nordisk Stock Near Its Near 52-Week Low?
11:36am, Wednesday, 19'th Nov 2025
Novo Nordisk (NVO +2.04%) stock is underperforming in 2025, and investors are interested in buying this stock on the dip.
Novo Resources Releases 2025 Sustainability Report Highlighting Commitment to Integrity, People and the Environment
10:20am, Wednesday, 19'th Nov 2025
PERTH, Western Australia, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (ASX: NVO) (TSX: NVO) (OTCQB: NSRPF) is pleased to announce the publication of its 2025 Sustaina
Avantax Advisory Services Inc. Sells 3,631 Shares of Novo Nordisk A/S $NVO
04:02am, Wednesday, 19'th Nov 2025
Avantax Advisory Services Inc. reduced its holdings in Novo Nordisk A/S (NYSE: NVO) by 3.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commissio
Why Big Pharma Won't Quit the Diet. Who Will Win the Next Weight Loss Battle?
04:00pm, Tuesday, 18'th Nov 2025
The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish line.
Novo Nordisk: A Rare Second Chance
10:35am, Tuesday, 18'th Nov 2025
Novo Nordisk is rated a 'Strong Buy' due to its undervaluation, wide economic moat, and long-term growth prospects despite recent setbacks. Novo Nordisk's Q3/25 results showed slowing growth, lowered
First Look: HD cuts outlook, NVDA watched, Alphabet stake, Novo cuts
07:37am, Tuesday, 18'th Nov 2025
Stock News Home Depot trims outlook after Q3 miss: Home Depot (HD) posted its third straight quarterly EPS miss, citing weaker home-improvement demand and fewer
Bridger Management LLC Sells 17,214 Shares of Novo Nordisk A/S $NVO
03:51am, Tuesday, 18'th Nov 2025
Bridger Management LLC lessened its holdings in shares of Novo Nordisk A/S (NYSE: NVO) by 14.2% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 104,386 share
Market Today: Nvidia earnings, Ford-Amazon tie-up, Boeing lands mega order
05:35pm, Monday, 17'th Nov 2025
Stock News Nvidia set to move markets: Nvidia (NVDA) reports Q3 results Wednesday; CEO Jensen Huang's October claim of $500B in 2025â26 orders will be in focu
Novo Nordisk: Modeling A GLP-1 Giant In Retreat And Recovery
04:25pm, Monday, 17'th Nov 2025
Novo Nordisk faces intensifying GLP-1 competition, notably from Eli Lilly, prompting price cuts for Wegovy to expand market access and defend share. NVO's long-term upside relies on broadening semaglu
Novo Holdings to sell 7.8% stake in UK's Convatec, bookrunner says
12:04pm, Monday, 17'th Nov 2025
Novo Holdings, which controls obesity drugmaker Novo Nordisk , will sell 155 million shares, or about 7.8% of its stake, in British medical products maker Convatec Group , a bookrunner for the offerin
NVO Down 10% in 3 Months: Is This an Indication to Sell the Stock?
11:26am, Monday, 17'th Nov 2025
Novo Nordisk stock falls 10% in three months as guidance cuts, GLP-1 rivalry and looming U.S. price resets cloud growth and elevate execution risks.
Novo Nordisk, Eli Lilly Weight Loss Price War Heats Up. Why It's a Worry for the Stocks.
11:22am, Monday, 17'th Nov 2025
Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.
